Get started
Author

Prachi Arora

Observed names: Arora, Prachi, P. Arora
ORCID: 0000-0002-7057-9033
Observed ORCID: 0000-0002-7057-9033
OpenAlex ID: A5080147908
Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C
2019 · B.E. Meyerson, J.D. Agley, et al. · Research in Social and Administrative Pharmacy · 43
PDF
Impact of telehealth on health care resource utilization during the COVID-19 pandemic
2022 · Prachi Arora, Darshan Mehta, et al. · Journal of Comparative Effectiveness Research · 24
Effects of the Affordable Care Act's Dependent Coverage Mandate on Private Health Insurance Coverage in Urban and Rural Areas
2016 · Kevin A. Look, Nam Hyo Kim, et al. · The Journal of Rural Health · 15
Effects of the Affordable Care Act's young adult insurance expansion on prescription drug insurance coverage, utilization, and expenditures
2015 · Kevin A. Look, Prachi Arora · Research in Social and Administrative Pharmacy · 15
A Cost-Effectiveness Study Comparing Ready-to-Administer and Traditional Vial-and-Syringe Method for Opioids
2022 · Prachi Arora, Maria Muehrcke, et al. · Pain and Therapy · 12
PDF
A Continuous Observation Workflow Time Study to Assess Intravenous Push Waste
2020 · John Hertig, Kaitlyn Jarrell, et al. · Hospital Pharmacy · 9
Factors influencing dabigatran or warfarin medication persistence in patients with nonvalvular atrial fibrillation
2018 · Srinivas Annavarapu, Pranav K Gandhi, et al. · Journal of Comparative Effectiveness Research · 7
Assessing Unmet and Latent Demand for Pharmacists at the State Level
2015 · Prachi Arora, David A. Mott, et al. · INNOVATIONS in pharmacy · 7
PDF
Antibiotic prescribing trends in the US during the first 11 months of the COVID-19 pandemic
2022 · Karishma Desai, Prachi Arora, et al. · Research in Social and Administrative Pharmacy · 6
Just the fax, please: Updating electronic/hybrid methods for surveying pharmacists
2018 · Jon Agley, Beth Meyerson, et al. · Research in Social and Administrative Pharmacy · 6
Comparison of all-cause, stroke, and bleed-specific healthcare resource utilization among patients with non-valvular atrial fibrillation (NVAF) and newly treated with dabigatran or warfarin
2017 · Xue Song, Pranav Gandhi, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 6
Assessing the Costs of Intravenous Push Waste in Intraoperative Areas Through Observation: A Multi-site Study
2024 · John B. Hertig, Les Louden, et al. · Drugs - Real World Outcomes · 4
PDF
Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States
2026 · Prachi Arora, Firas Dabbous, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2
Burden of infectious diseases and strategies of prevention
2023 · Karishma Desai, Prachi Arora · Elsevier eBooks · 2
Impact of comparative effectiveness research on Medicare coverage of direct oral anticoagulants
2022 · Prachi Arora, Maria Muehrcke, et al. · Journal of Comparative Effectiveness Research · 2
Does evidence matter? Comparative effectiveness research and prescribing of Type 2 diabetes mellitus drugs
2019 · Prachi Arora, Kevin A Look, et al. · Journal of Comparative Effectiveness Research · 2
Utilization outcomes of direct oral anticoagulants in Medicare patients
2023 · Prachi Arora, Maria Muehrcke, et al. · Research in Social and Administrative Pharmacy · 1
Comparison of Stroke- and Bleed-Specific Healthcare Resource Utilization and Costs Among Patients with Non-Valvular Atrial Fibrillation, Newly Treated with Dabigatran or Warfarin
2016 · Xue Song, Pranav Gandhi, et al. · Blood · 1
Manufacturer-Prepared Ready-to-Use versus Traditional IV Piggyback Preparation: A Combined Process-Error, Workforce-Time-Waste, and Cost-Effectiveness Analysis
2026 · John B. Hertig, Les Louden, et al. · Preprints.org
Su1988 REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH MASH/MASLD STRATIFIED BY FIBROSIS SEVERITY
2026 · Prachi Arora, Subash C, et al. · Gastroenterology
Su1988 REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH MASH/MASLD STRATIFIED BY FIBROSIS SEVERITY
2026 · Prachi Arora, Subash C, et al. · Gastrointestinal Endoscopy
Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States
2026 · Arora, Prachi, Dabbous, Firas, et al. · Figshare
Effects of semaglutide on one-year medical costs among patients with obesity or overweight in US real world setting
2025 · Prachi Arora, Wojciech Michalak, et al. · Expert Review of Pharmacoeconomics & Outcomes Research
PDF
HSD23 Comparison of Drug Utilization Outcomes of Direct Oral Anticoagulants in Medicare Patients
2023 · P. Arora, M. Muehrcke, et al. · Value in Health
PDF
Contributors
2023 · Krishnendu Adhikary, Brenda Affinati, et al. · Elsevier eBooks
Works count: 28
Citation count: 164
H-index: 7
I10-index: 5
Year
Topic
Type